glutamine has been researched along with Disease Exacerbation in 87 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 20 (22.99) | 29.6817 |
| 2010's | 42 (48.28) | 24.3611 |
| 2020's | 25 (28.74) | 2.80 |
| Authors | Studies |
|---|---|
| Du, J; Hu, W; Huang, Z; Li, Y; Tong, X; Wang, X; Wang, Y; Xia, J; Zhou, Y | 1 |
| Albrecht, J; Aldana, BI; Belfiori-Carrasco, LF; Czarnecka, AM; Obara-Michlewska, M; Pawlik, MJ; Popek, MP | 1 |
| Cao, J; Li, L; Wang, J; Yang, K | 1 |
| Al Khleifat, A; Al-Chalabi, A; Amouyel, P; Andersen, PM; Assialioui, A; Ataulina, A; Baird, D; Bakker, MK; Bakker, OB; Baloh, RH; Barthel, T; Başak, N; Beghi, E; Bell, S; Bensimon, G; Benyamin, B; Blair, IP; Braun, A; Breen, G; Brenner, D; Brice, A; Brown, RH; Brunetti, M; Brylev, L; Byrne, RP; Calvo, A; Canosa, A; Cauchi, RJ; Cereda, C; Chandran, S; Chiò, A; Cichon, S; Cooper-Knock, J; Corcia, P; Corti, S; Couratier, P; Curtis, CJ; D'Alfonso, S; Davey Smith, G; de Carvalho, M; de Klein, N; Deelen, P; Dekker, AM; Demeshonok, V; Dion, PA; Doherty, M; Dolzhenko, E; Drory, V; Durr, A; Eberle, MA; Fan, D; Filosto, M; Fogh, I; Fominykh, V; Franke, A; Franke, L; Freischmidt, A; Furlong, S; Garton, FC; Gaunt, TR; Gaur, N; Gawor, K; Gellera, C; Glass, JD; Glavač, D; Gotkine, M; Graff, C; Grassano, M; Groen, EJN; Gromicho, M; Grosskreutz, J; Hannon, E; Hardiman, O; Hardy, J; Henders, AK; Henderson, RD; Heverin, M; Hofman, A; Hop, PJ; Hübner, CA; Iacoangeli, A; Ilse, B; Jörk, A; Kenna, KP; Kiernan, MC; Kooyman, M; Koritnik, B; Kraft, J; Landers, JE; Lauria, G; Lerner, Y; Lieb, W; Logroscino, G; Lomen-Hoerth, C; Ludolph, AC; Mather, KA; Mathers, S; McCombe, PA; McLaughlin, RL; McRae, AF; Meininger, V; Meyer, T; Mill, J; Millecamps, S; Mitne Neto, M; Moglia, C; Moisse, M; Mora Pardina, JS; Morrison, KE; Needham, M; Nefussy, B; Ngo, ST; Nicholson, GA; Nordin, A; Nöthen, MM; Olsen, CM; Ophoff, RA; Orrell, RW; Osmanovic, A; Padovani, A; Pal, S; Pamphlett, R; Pasterkamp, RJ; Payan, CAM; Petri, S; Pinto, S; Povedano, M; Pupillo, E; Rademakers, R; Ratti, A; Ravnik-Glavač, M; Restuadi, R; Rietschel, M; Ripke, S; Roediger, A; Rogelj, B; Rojas-García, R; Ross, JP; Rouleau, GA; Rowe, DB; Runz, H; Sachdev, PS; Saker-Delye, S; Salachas, F; Sendtner, M; Shatunov, A; Shaw, CE; Shaw, PJ; Shireby, G; Siciliano, G; Silani, V; Singleton, AB; Smith, BN; Sorarù, G; Sproviero, D; Steinbach, R; Stević, Z; Steyn, FJ; Stubendorff, B; Tazelaar, GHP; Theele, E; Ticozzi, N; Tittmann, L; Topp, S; Traynor, BJ; Tsai, E; Uitterlinden, AG; Van Damme, P; van Deerlin, VM; van den Berg, LH; van der Kooi, AJ; van der Spek, RAA; van Eijk, KR; van Es, MA; van Rheenen, W; van Vugt, JJFA; Veldink, JH; Vourc'h, P; Wallace, L; Weber, M; Weishaupt, JH; Westeneng, HJ; Westra, HJ; Whiteman, DC; Wiedau-Pazos, M; Williams, KL; Witte, OW; Wood, NW; Wray, NR; Zabari, M; Zidar, J; Zwamborn, RAJ | 1 |
| Fortuin, R; Sitole, L; Tugizimana, F | 1 |
| Dong, ZY; Jin, WJ; Liu, M; Peng, L; Xu, MY; You, H; Zhou, C | 1 |
| Bäckhed, F; Buffa, JA; Demuth, I; Fischbach, MA; Haghikia, A; Hazen, SL; König, M; Landmesser, U; Li, L; Li, XS; Nemet, I; Romano, KA; Steinhagen-Thiessen, E; Tang, WHW; Wilcox, J; Witkowski, M | 1 |
| Howell, CM; Monus, T | 1 |
| Aburatani, H; Anai, M; Ando, R; Anwar, M; Endo, K; Hamada, A; Hanada, K; Hasegawa, Y; Hayashi, M; Hino, S; Igarashi, K; Ishii, N; Kanki, Y; Kato, K; Kodama, T; Kondo, A; Matsumura, Y; Minami, T; Miyano, S; Nakao, M; Nishida, M; Osawa, T; Saito, K; Saitoh, K; Sakai, J; Sakamoto, A; Shibuya, M; Shimamura, T; Soga, T; Tanaka, T; Tsuchida, R; Wada, Y; Wanibuchi, H; Yachida, S; Yamano, S; Yoshida, M | 1 |
| Blicher, JU; Eskildsen, SF; Figlewski, K; Møller, AT; Near, J; Stærmose, TG | 1 |
| Huang, Y; Jin, R; Liu, R; Luo, J; Shuai, Y; Wang, X; Zhang, Z | 1 |
| Chen, J; Wei, D; Wu, J; Wu, S; Xu, G; Zhang, S | 1 |
| Abdelmalek, MF; Bashir, MR; Chitneni, SK; Diehl, AM; Du, K; Henao, R; Hyun, J; Moylan, CA; Naggie, S; Premont, RT; Suzuki, A; Wang, Y | 1 |
| Danda, D; Goel, R; Guleria, A; Jain, A; Kumar, D; Kumar, U; Misra, DP; Misra, R; R, VK | 1 |
| Bamba, T; Izumi, Y; Kodama, M; Matsumoto, M; Nakayama, KI; Oshikawa, K; Shimizu, H; Takahashi, M; Tateishi, C; Tomonaga, T; Yoshioka, S | 1 |
| Hu, M; Huang, P; Kong, B; Li, X; Li, Y; Ling, S; Ma, Y | 1 |
| Guan, Y; Guo, J; He, Y; Jia, W; Jian, X; Lei, Q; Li, G; Li, J; Lin, J; Ouyang, J; Qiu, L; Su, M; Wang, J; Wang, Y; Wu, M; Xia, J; Xiang, J; Xie, L; Zhang, J; Zhou, W; Zhu, Y | 1 |
| Cheng, ML; Lai, MW; Liang, KH; Lin, WR; Lin, YH; Lo, CJ; Yeh, CT | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Andres-Mach, M; Chudzik, A; Kochalska, K; Kozioł, P; Oakden, W; Orzylowska, A; Pankowska, A; Pietura, R; Rola, R; Stanisz, GJ; Słowik, T; Łazorczyk, A | 1 |
| Ekici, S; Fleischer, CC; Neill, SG; Risk, BB; Shu, HK | 1 |
| Akman, M; Belisario, DC; De Smaele, E; Donadelli, M; Kopecka, J; Pasino, M; Riganti, C | 1 |
| Braissant, O; Capobianco, D; Cudalbu, C; DeMorrow, S; Flatt, E; Grosse, J; Mastromarino, P; McLin, VA; McMillin, M; Rackayová, V | 1 |
| Chen, S; Li, S; Qian, C; Wang, Y; Yao, J | 1 |
| Arshad, M; Bjørklund, G; Butnariu, M; Gasmi, A; Menzel, A; Peana, M | 1 |
| Beasley, J; Chang, Y; Chen, X; Dong, X; Gao, X; George, D; Groth, J; He, Y; Hu, H; Huang, J; Li, Y; Liu, J; Locasale, JW; McCaw, P; Tang, DG; Wang, Q; Xu, L; Yin, Y; Young, S; Zhang, H | 1 |
| Gao, Z; Guan, J; Huang, W; Li, N; Liu, F; Liu, Y; Wang, F; Wang, S; Wang, X; Xu, C; Yi, H; Zhang, N; Zhang, X | 1 |
| Sun, L; Xin, Y; Yang, X; Yu, W; Yuan, S; Zhang, Q | 1 |
| Ansari, J; Gavins, FNE; Moufarrej, YE; Pawlinski, R | 1 |
| Dutta, T; Ghosh, T; Gonsalves, WI; Hitosugi, T; Jevremovic, D; Kumar, SK; Nair, KS; Petterson, XM; Ramakrishnan, V; Sakrikar, D; Wellik, L | 1 |
| Antonyak, MA; Cerione, RA; Katt, WP | 1 |
| Carroll, TJ; DeBerardinis, RJ; Flowers, EM; Mernaugh, G; Sudderth, J; Zacharias, L; Zent, R | 1 |
| Eisenberg, R; Harris, BK; Heidi, C; Hoeksema, MD; Ji, X; Massion, PP; Qian, J; Rahman, SMJ; Rathmell, JC; Siska, PJ; Trenary, IA; Young, JD; Zou, Y | 1 |
| Dorai, T; Hsieh, TC; Huang, J; Mathew, R; Shah, A; Summers, F; Wu, JM | 1 |
| Bettigole, SE; Cerliani, JP; Chae, CS; Chaurio, RA; Chopra, S; Conejo-Garcia, JR; Crowley, MJP; Cubillos-Ruiz, JR; Glimcher, LH; Holcomb, K; Konrad, C; Kossenkov, AV; Manfredi, G; Motorykin, I; Payne, KK; Rabinovich, GA; Raundhal, M; Rodriguez, PC; Rutkowski, MR; Sandoval, TA; Shin, HR; Song, M; Tan, C; Zamarin, D; Zhang, S | 1 |
| Hammoud, DA; Maric, D; Miller, LH; Munasinghe, JP; Pierce, SK; Powell, JD; Prchalova, E; Riggle, BA; Schreiber-Stainthorp, W; Sinharay, S; Slusher, BS | 1 |
| Chen, W; Ren, H; Wang, B; Wang, J | 1 |
| Chang, PH; Chou, WC; Fan, CW; Huang, JS; Ling, HH; Pan, YP; Tseng, WK; Wang, CH; Wu, TH; Yeh, KY | 1 |
| Cao, J; Gan, M; Guo, M; Han, T; Jin, J; Wang, JB; Wang, P; Wang, Y; Xie, C; Zhang, S | 1 |
| Fingleton, B; Williams, D | 1 |
| Guo, C; Lv, R; Pan, X; Song, L; Sun, Q; Zhou, Q; Zou, S | 1 |
| Long, JD; Paulsen, JS; Smith, MM | 1 |
| Abe, O; Aoki, Y; Gonoi, W; Inoue, H; Iwashiro, N; Kasai, K; Katsura, M; Koike, S; Natsubori, T; Sasaki, H; Takano, Y; Takao, H; Yahata, N; Yamasue, H | 1 |
| Chan, DA; Daemen, A; Ethier, SP; Gray, JW; Holton, T; Hu, M; Louie, RJ; McCormick, F; Padró, M; Polyak, K; Timmerman, LA; van 't Veer, LJ; Yuneva, M | 1 |
| Cao, Z; Chen, Y; Dai, H; Li, H; Lin, Y; Pang, L; Wu, R; Yao, J; You, K | 1 |
| Burzynski, GS; Burzynski, SR; Janicki, TJ; Marszalek, A | 1 |
| Clerici, CA; Massimino, M | 1 |
| Di Rocco, C | 1 |
| Gao, L; Pan, T; Qian, W; Shen, G; Tu, Z; Wen, H; Wu, G; Xie, S; Yang, J; Zhou, Y | 1 |
| Brennan, CW; Campos, C; Carlin, SD; Cross, JR; Dunphy, MP; Holland, EC; Kung, HF; La Rocca, G; Lewis, JS; Lyashchenko, S; Mellinghoff, IK; Omuro, AM; Pitter, KL; Ploessl, K; Rohle, D; Thompson, CB; Venneti, S; Weber, WA; Zanzonico, P; Zhang, H | 1 |
| Cai, C; Chen, R; Fu, Z; Gong, Y; Han, F; Li, Y; Li, Z; Lin, Q; Liu, G; Tang, C; Yang, B; Ye, H; Ye, L; Yu, M; Zeng, B; Zhao, X; Zhou, Q; Zhou, Y; Zhu, J | 1 |
| Adam, SJ; Bellovin, DI; Casey, SC; Dang, CV; Dang, VM; Eberlin, LS; Felsher, DW; Gabay, M; Garcia-Ocana, A; Gouw, AM; Li, Y; Philbrick, WM; Shroff, EH; Tran, PT; Zare, RN | 1 |
| Freedman, MS; Kolind, SH; Li, DK; MacMillan, EL; Oger, J; Tam, R; Traboulsee, AL; Vavasour, IM; Zhao, Y | 1 |
| Colvin, H; Doki, Y; Hamabe, A; Hata, T; Ishii, H; Kawamoto, K; Konno, M; Koseki, J; Miyo, M; Mizushima, T; Mori, M; Nishida, N; Nishimura, J; Ogawa, H; Takemasa, I; Uemura, M; Yamamoto, H | 1 |
| Aleman, A; Bais, L; de Vos, A; Dlabac-De Lange, J; Knegtering, H; Liemburg, E; Opmeer, E; Pijnenborg, G; Sibeijn-Kuiper, A; van der Velde, J; Wunderink, L | 1 |
| Brunet-Vega, A; Calvet, X; Gombau, L; Junquera, F; Kuligowski, J; Lario, S; Pericay, C; Quintás, G; Ramírez-Lázaro, MJ; Sanjuan-Herráez, D; Vázquez-Sánchez, MA | 1 |
| Achreja, A; Baddour, J; Choi, HH; Han, C; Huang, C; Ji, G; Li, J; Li, Y; Liu, Y; Lu, X; Nagrath, D; Wan, G; Yang, L; Zhang, X | 1 |
| Campagna, G; Grilli, A; La Fratta, I; Pesce, M; Rizzuto, A; Tatangelo, R | 1 |
| Chen, XM; Deng, DP; Li, SC; Liu, YX; Pan, XH; Sun, HL; Wang, QY; Zhang, JR; Zhang, YR; Zhu, W | 1 |
| Chang, JZ; Hong, CY; Hou, KL; Kok, SH; Lai, EH; Lin, LD; Lin, SK; Wang, HW; Wang, JS; Yang, H | 1 |
| Barres, BA; Cerda, SR; Dugas, J; Popko, B; Traka, M; Wollmann, RL | 1 |
| Carroll, CL; Schramm, CM; Stoltz, P; Zucker, AR | 1 |
| Frölich, L; Kratzsch, T; Lais, C; Lanfermann, H; Maurer, K; Pantel, J; Pilatus, U; Rochmont, Adu M; Zanella, FE | 1 |
| Cakir, E; Dalgic, N; Kayaalti, Z; Kilic, B; Kutlubay, B; Odabasi, M; Sancar, M; Soylemezoglu, T; Tekin, D | 1 |
| Anderson, J; Jones, BW; Kondo, M; Lin, Y; Marc, RE; Rapp, K; Shaw, MV; Terasaki, H; Watt, CB; Yang, JH | 1 |
| Davis-Malesevich, M; Fokt, I; Frederick, MJ; Myers, JN; Ow, TJ; Pickering, CR; Priebe, W; Sandulache, VC; Zhou, G | 1 |
| Gomez-Esteban, JC; Lezcano, E; Molano, A; Somme, JH; Tijero, B; Zarranz, JJ | 1 |
| Beland, FA; Pogribny, IP; Simpson, NE; Tryndyak, VP | 1 |
| Barcikowska, M; Ćwikła, JB; Gabryelewicz, T; Walecki, J | 1 |
| Hattori, K; Hori, H; Ishikawa, M; Kunugi, H; Nakata, Y; Ota, M; Sasayama, D; Sato, N; Teraishi, T | 1 |
| Brinker, T; Kondziella, D; Lüdemann, W; Qu, H; Sletvold, O; Sonnewald, U | 1 |
| Azzedine, H; Brice, A; Dubourg, O; Ente, D; Gilardeau, C; LeGuern, E; Périé, S; Ruberg, M; Wechsler, B | 1 |
| Al-Hassnan, ZN; Boyadjiev, SA; Braverman, NE; Geraghty, MT; Hamosh, A; Praphanphoj, V; Thomas, GH | 1 |
| Barbier, P; Bourgarel-Rey, V; Braguer, D; Campbell, GR; de Mareuil, J; Esquieu, D; Kaleebu, P; Loret, EP; Pasquier, E; Peyrot, V; Watkins, J; Yirrell, DL | 1 |
| Bestak, M; Burzynski, SR; Janicki, TJ; Jurida, GF; Khan, MI; Lewy, RI; Szymkowski, BG; Weaver, RA | 1 |
| Ashwal, S; Gross, M; Holshouser, B; Kido, D; Osterdock, R; Serna, T; Tong, K | 1 |
| Bjoraker, KJ; Charnas, LR; Choi, IY; Gruetter, R; Oz, G; Shapiro, EG; Tkác, I | 1 |
| Burzynski, SR; Dolgopolov, V; Janicki, T; Jurida, G; Khan, M; Szymkowski, B; Weaver, RA | 1 |
| Abrahamsson, PA; Ahlgren, G; Gadaleanu, V; Giwercman, A; Giwercman, YL | 1 |
| Bischoff, SC; Borchert, K; Lochs, H; Manns, MP; Ockenga, J; Stüber, E | 1 |
| Bubb, WA; Hunt, NH; Parekh, SB; Rae, C | 1 |
| Hegazi, RA; O'Keefe, SJ | 1 |
| Angenstein, F; Debska-Vielhaber, G; Heinze, HJ; Hilfert, L; Kunz, WS; Leibfritz, D; Ludolph, AC; Niessen, HG; Sander, K; Vielhaber, S; Willker, W | 1 |
| Au, WL; Lim, CC; Wong, YC; Xu, M; Ye, J | 1 |
| Andermann, E; Andermann, F; Cao, H; De Meirleir, L; Hegele, RA; Jansen, AC; Kaplan, P; Leonard, G; Liebaers, I; Lissens, W; Silver, K; Veilleux, M | 1 |
| Cadet, JL; Duan, W; Ford, E; Ladenheim, B; Masuda, N; Peng, Q; Ross, CA; Tryggestad, E; Wong, J; Zhao, M | 1 |
| Arai, K; Fujigasaki, H; Fukuda, T; Funata, N; Hattori, T; Takahashi, J; Tanaka, J; Uchihara, T | 1 |
12 review(s) available for glutamine and Disease Exacerbation
| Article | Year |
|---|---|
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology.
Topics: Amyotrophic Lateral Sclerosis; Brain; Cholesterol; Disease Progression; Female; Genome-Wide Association Study; Glutamine; Humans; Male; Mendelian Randomization Analysis; Microsatellite Repeats; Mutation; Neurodegenerative Diseases; Neurons; Quantitative Trait Loci; Risk Factors; RNA-Seq | 2021 |
Current and emerging treatments for sickle cell disease.
Topics: Acute Chest Syndrome; Acute Disease; Analgesics, Opioid; Anemia, Sickle Cell; Anti-Bacterial Agents; Antisickling Agents; Chronic Disease; Disease Progression; Erythrocyte Transfusion; Fluid Therapy; Genetic Therapy; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Infant, Newborn; Infection Control; Infections; Mesenteric Ischemia; Neonatal Screening; Oxygen Inhalation Therapy; Pain Management; Patient Education as Topic; Pneumococcal Infections; Pneumococcal Vaccines; Stroke | 2019 |
Essential Role of Nonessential Amino Acid Glutamine in Atherosclerotic Cardiovascular Disease.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Disease Progression; Glutamine; Humans; Macrophage Activation; Myocardial Reperfusion Injury; Neovascularization, Pathologic; Oxidative Stress | 2020 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance.
Topics: Amino Acids; Animals; Citric Acid Cycle; Dimerization; Disease Progression; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Glucose; Glutamine; Humans; Hypoxia; Lactic Acid; Mice; Mitochondria; Neoplasms; Oxidation-Reduction; Oxidative Phosphorylation; Oxygen; Phenotype; Reactive Oxygen Species; Tumor Microenvironment | 2020 |
Krebs cycle: activators, inhibitors and their roles in the modulation of carcinogenesis.
Topics: Animals; Carcinogenesis; Citric Acid Cycle; Disease Progression; Energy Metabolism; Glucose; Glutamine; Glycolysis; Humans; L-Lactate Dehydrogenase; Neoplasms; Oxygen Consumption | 2021 |
Targeting GLS1 to cancer therapy through glutamine metabolism.
Topics: Apoptosis; Benzophenanthridines; Cell Proliferation; Diazooxonorleucine; Disease Progression; Drug Resistance, Neoplasm; Genes, myc; Glutaminase; Glutamine; Humans; MicroRNAs; Neoplasm Proteins; Neoplasms; NF-kappa B; Oxidation-Reduction; Phosphates; Prognosis; Retinoblastoma Protein; Sulfides; Thiadiazoles | 2021 |
Sickle cell disease: a malady beyond a hemoglobin defect in cerebrovascular disease.
Topics: Anemia, Sickle Cell; Antisickling Agents; Cell Communication; Cerebrovascular Disorders; Disease Progression; Glutamine; Hemoglobins; Humans; Hydroxyurea; Inflammation; Mutation; Neutrophils; Quality of Life | 2018 |
The diamond anniversary of tissue transglutaminase: a protein of many talents.
Topics: Amines; Animals; Disease Progression; Glutamine; GTP-Binding Proteins; Humans; Neoplasms; Transglutaminases | 2018 |
Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis.
Topics: ATP Citrate (pro-S)-Lyase; Disease Progression; Energy Metabolism; Fatty Acids; Glucose; Glucose-6-Phosphate Isomerase; Glutaminase; Glutamine; Humans; Isocitrate Dehydrogenase; Neoplasm Metastasis; Neoplasms | 2019 |
The progression of coeliac disease: its neurological and psychiatric implications.
Topics: Adult; Celiac Disease; Cognitive Dysfunction; Diet, Gluten-Free; Disease Progression; Edible Grain; Environment; Female; Genetic Predisposition to Disease; Glutamine; Humans; Immune System Diseases; Immunity; Male; Mental Disorders; Middle Aged; Nervous System Diseases; Plant Proteins; Proline | 2017 |
Nutritional immunomodulation of acute pancreatitis.
Topics: Acute Disease; Animals; Cytokines; Disease Progression; Enteral Nutrition; Food, Formulated; Glutamine; HSP70 Heat-Shock Proteins; Humans; Hyperglycemia; Multiple Organ Failure; Pancreatitis; Parenteral Nutrition, Total; Probiotics; Th2 Cells; Treatment Outcome | 2007 |
7 trial(s) available for glutamine and Disease Exacerbation
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Brain Stem Neoplasms; Child; Child, Preschool; Disease Progression; Drug Combinations; Female; Glioma; Glutamine; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Pons; Survival Rate | 2014 |
Commentary: The response and survival of children with recurrent diffuse intrisic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma, by Burzynski G, et al.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Biomedical Research; Brain Stem Neoplasms; Child; Child, Preschool; Disease Progression; Drug Combinations; Female; Glioma; Glutamine; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Pons; Prognosis; Survival Rate; Treatment Outcome | 2014 |
Main editor's comment to the paper: the response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma. Stanislaw R. Burzynski, Tomasz J. Janicki
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Brain Stem Neoplasms; Child; Child, Preschool; Disease Progression; Drug Combinations; Female; Glioma; Glutamine; Humans; Infusions, Intravenous; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Pons; Survival Rate; Treatment Outcome | 2014 |
Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report.
Topics: Adolescent; Antineoplastic Agents; Astrocytoma; Benzeneacetamides; Brain Neoplasms; Child; Child, Preschool; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Glioma; Glutamine; Humans; Infant; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome | 2004 |
Long-term survival of high-risk pediatric patients with primitive neuroectodermal tumors treated with antineoplastons A10 and AS2-1.
Topics: Antineoplastic Agents; Benzeneacetamides; Brain Neoplasms; Child, Preschool; Disease Progression; Drug Combinations; Drug Therapy, Combination; Female; Glutamine; Humans; Infant; Male; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive; Phenylacetates; Piperidones; Survival Analysis; Treatment Outcome | 2005 |
Glutamine-enriched total parenteral nutrition in patients with inflammatory bowel disease.
Topics: Acute Disease; Adult; Dietary Supplements; Dipeptides; Disease Progression; Female; Glutamine; Humans; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Lactulose; Male; Middle Aged; Nitrogen; Nutritional Status; Parenteral Nutrition, Total; Permeability; Sample Size; Time Factors; Xylose | 2005 |
69 other study(ies) available for glutamine and Disease Exacerbation
| Article | Year |
|---|---|
CISD3 inhibition drives cystine-deprivation induced ferroptosis.
Topics: Animals; Cell Line, Tumor; Cell Survival; Cystine; Disease Progression; Ferroptosis; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glutamine; Homeostasis; Humans; Iron; Iron-Sulfur Proteins; Lipid Peroxides; Mice, Nude; Mitochondria; Mitochondrial Dynamics; Mitochondrial Proteins; Mitophagy; Neoplasms; Organophosphorus Compounds; Piperazines; Ubiquinone; Xenograft Model Antitumor Assays | 2021 |
Inhibition of Glutamate Release, but Not of Glutamine Recycling to Glutamate, Is Involved in Delaying the Onset of Initial Lithium-Pilocarpine-Induced Seizures in Young Rats by a Non-Convulsive MSO Dose.
Topics: Animals; Brain; Disease Progression; Dose-Response Relationship, Drug; Glutamic Acid; Glutamine; Lithium; Male; Methionine Sulfoximine; Pilocarpine; Rats; Rats, Sprague-Dawley; Secretory Pathway; Seizures | 2021 |
Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.
Topics: Amino Acid Transport System ASC; Animals; Apoptosis; Base Sequence; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dipeptides; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Glutamine; Humans; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Minor Histocompatibility Antigens; Protein Binding; RNA, Circular; RNA, Messenger | 2021 |
Metabolic profiling of HIV infected individuals on an AZT-based antiretroviral treatment regimen reveals persistent oxidative stress.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Arginine; Biomarkers; Disease Progression; Glucose; Glutamates; Glutamine; Glutathione; HIV Infections; Humans; Oxidative Stress; Reproducibility of Results; Zidovudine | 2022 |
A Novel Metabolic Score for Predicting the Acute Exacerbation in Patients with Chronic Obstructive Pulmonary Disease.
Topics: Disease Progression; Glutamine; Humans; Isoleucine; Pulmonary Disease, Chronic Obstructive; Pyruvates | 2023 |
Atlas of gut microbe-derived products from aromatic amino acids and risk of cardiovascular morbidity and mortality.
Topics: Amino Acids, Aromatic; Animals; Disease Progression; Gastrointestinal Microbiome; Glucuronides; Glutamine; Humans; Indoles; Mice; Myocardial Infarction; Tryptophan; Tyrosine | 2023 |
Phosphoethanolamine Accumulation Protects Cancer Cells under Glutamine Starvation through Downregulation of PCYT2.
Topics: Animals; Cell Line; Cell Line, Tumor; Disease Progression; Down-Regulation; Ethanolamines; Glutamine; HeLa Cells; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; MCF-7 Cells; Mice, Inbred C57BL; Proto-Oncogene Proteins c-ets; RNA Nucleotidyltransferases; Starvation; Transcription, Genetic | 2019 |
Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3 T.
Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; Atrophy; Choline; Creatine; Disease Progression; Female; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glutathione; Gray Matter; Hand Strength; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Occipital Lobe; Pilot Projects; Severity of Illness Index; Single-Blind Method | 2019 |
ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
Topics: Amino Acid Transport System ASC; Animals; Antineoplastic Agents, Immunological; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cetuximab; Disease Progression; Female; Glutamine; Head and Neck Neoplasms; Humans; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Nude; Minor Histocompatibility Antigens; Oxidative Stress; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Transfection; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression.
Topics: Adult; Amino Acid Transport System ASC; Animals; Biomarkers; Cell Line; Cicatrix; Disease Models, Animal; Disease Progression; Female; Glutaminase; Glutamine; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Male; Metabolomics; Mice; Middle Aged; Minor Histocompatibility Antigens; Myofibroblasts; Non-alcoholic Fatty Liver Disease; Positron-Emission Tomography | 2020 |
Circulatory Glutamine/Glucose ratio for evaluating disease activity in Takayasu arteritis: A NMR based serum metabolomics study.
Topics: Adult; Blood Glucose; Blood Sedimentation; Disease Progression; Female; Glucose; Glutamine; Humans; Male; Metabolomics; Nuclear Magnetic Resonance, Biomolecular; Prospective Studies; ROC Curve; Severity of Illness Index; Takayasu Arteritis; Young Adult | 2020 |
A shift in glutamine nitrogen metabolism contributes to the malignant progression of cancer.
Topics: Amidophosphoribosyltransferase; Animals; Biosynthetic Pathways; Cell Line, Tumor; Disease Progression; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Humans; Metabolomics; Mice, Nude; Models, Biological; Molecular Targeted Therapy; Neoplasms; Nitrogen; Prognosis | 2020 |
Loss of heterozygosity for Kras
Topics: Adenocarcinoma; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Hypoxia; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Knockdown Techniques; Glutamine; Humans; Loss of Heterozygosity; Mutation; Neoplasm Invasiveness; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Transcription Factors | 2020 |
Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria.
Topics: Animals; Bacteria; Biodiversity; China; Disease Progression; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Glutamine; Host Microbial Interactions; Humans; Klebsiella; Metagenome; Mice; Multiple Myeloma; Streptococcus | 2020 |
Plasma phenylalanine and glutamine concentrations correlate with subsequent hepatocellular carcinoma occurrence in liver cirrhosis patients: an exploratory study.
Topics: Age Factors; Aged; Area Under Curve; Carcinoma, Hepatocellular; Chromatography, Liquid; Cross-Sectional Studies; Disease Progression; Female; Glutamine; Humans; Liver Cirrhosis; Male; Middle Aged; Nuclear Magnetic Resonance, Biomolecular; Phenylalanine; Prodromal Symptoms; Prospective Studies; Risk; ROC Curve | 2020 |
Dietary supplementation with Lactobacillus rhamnosus JB-1 restores brain neurochemical balance and mitigates the progression of mood disorder in a rat model of chronic unpredictable mild stress.
Topics: Animals; Aspartic Acid; Behavior, Animal; Brain; Choline; Depressive Disorder; Dietary Supplements; Disease Progression; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glutathione; Lacticaseibacillus rhamnosus; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Wistar; Stress, Psychological | 2020 |
Characterization of dysregulated glutamine metabolism in human glioma tissue with
Topics: Adult; Aged; Biomarkers, Tumor; Brain Neoplasms; Disease Progression; Female; Glioma; Glutamine; Humans; Interleukin-1beta; Interleukin-8; Middle Aged; Neoplasm Grading; Pilot Projects; Principal Component Analysis; Proton Magnetic Resonance Spectroscopy | 2020 |
Probiotics improve the neurometabolic profile of rats with chronic cholestatic liver disease.
Topics: Ammonium Compounds; Animals; Behavior, Animal; Bifidobacterium; Bile Ducts; Bilirubin; Blood Glucose; Body Weight; Brain; Cholestasis; Disease Progression; Feces; Gastrointestinal Microbiome; Glutamine; Inositol; Ligation; Liver Diseases; Male; Metabolome; Probiotics; Proton Magnetic Resonance Spectroscopy; Rats, Wistar | 2021 |
Circ_0000003 regulates glutamine metabolism and tumor progression of tongue squamous cell carcinoma via the miR‑330‑3p/GLS axis.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Gene Knockdown Techniques; Glutaminase; Glutamine; Humans; MicroRNAs; Neoplasm Invasiveness; RNA, Circular; Squamous Cell Carcinoma of Head and Neck; Tongue; Tongue Neoplasms; Up-Regulation | 2021 |
A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.
Topics: Androgen Antagonists; Animals; Cell Line, Tumor; Computational Biology; Disease Progression; Drug Resistance, Neoplasm; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutaminase; Glutamine; Humans; Isoenzymes; Male; Mice; Prostate; Prostatic Neoplasms; Receptors, Androgen; Tissue Array Analysis; Xenograft Model Antitumor Assays | 2021 |
A novel tumor suppressor CECR2 down regulation links glutamine metabolism contributes tumor growth in laryngeal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Animals; Cell Count; Cell Line, Tumor; Cell Proliferation; Disease Progression; Down-Regulation; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Glutamine; Humans; Ketoglutaric Acids; Laryngeal Neoplasms; Male; Mice; Mice, Nude; Middle Aged; Mitochondria; Neoplasm Proteins; Oxygen Consumption; Squamous Cell Carcinoma of Head and Neck; Transcription Factors | 2021 |
Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies.
Topics: Biomarkers, Tumor; Cell Line, Tumor; Citric Acid Cycle; Disease Progression; DNA-Binding Proteins; Glucose; Glutamine; Glutarates; Glycolysis; Humans; Lactic Acid; Multiple Myeloma; Multivariate Analysis; Neoplasms; Plasma Cells; Transcription Factors | 2018 |
Lkb1 deficiency confers glutamine dependency in polycystic kidney disease.
Topics: AMP-Activated Protein Kinases; Animals; Disease Progression; Female; Glutamine; Humans; Kidney; Male; Mice; Mice, Knockout; Polycystic Kidney Diseases; Protein Serine-Threonine Kinases | 2018 |
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression.
Topics: 3T3 Cells; A549 Cells; Amino Acid Transport System y+; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cystine; Cytoplasm; Disease Progression; Female; Glutamine; Humans; Lung Neoplasms; Male; Mice; Middle Aged | 2018 |
NRH:quinone oxidoreductase 2 (NQO2) and glutaminase (GLS) both play a role in large extracellular vesicles (LEV) formation in preclinical LNCaP-C4-2B prostate cancer model of progressive metastasis.
Topics: Amino Acid Sequence; Binding Sites; Caveolin 1; Cell Line, Tumor; Disease Progression; Extracellular Vesicles; Glutaminase; Glutamine; Humans; Immunoblotting; Male; Models, Molecular; NAD(P)H Dehydrogenase (Quinone); Neoplasm Metastasis; Oxidative Stress; Prostatic Neoplasms; Quinone Reductases | 2018 |
IRE1α-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity.
Topics: Amino Acid Transport Systems, Basic; Animals; Ascites; Cell Respiration; Disease Progression; Endoplasmic Reticulum Stress; Endoribonucleases; Female; Gene Expression Regulation, Neoplastic; Glucose; Glutamine; Glycosylation; Humans; Interferon-gamma; Mice; Mitochondria; Neoplasm Metastasis; Neoplasm Transplantation; Ovarian Neoplasms; Protein Serine-Threonine Kinases; Signal Transduction; Survival Rate; T-Lymphocytes; Tumor Escape; Unfolded Protein Response; X-Box Binding Protein 1 | 2018 |
MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice.
Topics: Adult; Animals; Antimalarials; Biomarkers; Blood-Brain Barrier; Brain; Brain Edema; Child; Diazooxonorleucine; Disease Models, Animal; Disease Progression; Female; Glutamine; Humans; Magnetic Resonance Imaging; Malaria, Cerebral; Malaria, Falciparum; Mice; Mice, Inbred C57BL; Plasmodium falciparum | 2018 |
miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1.
Topics: 3' Untranslated Regions; Aspartate Aminotransferase, Cytoplasmic; Cell Line, Tumor; Cell Proliferation; Disease Progression; Down-Regulation; Gene Expression Regulation, Neoplastic; Glutamine; Humans; MicroRNAs; Neoplasm Invasiveness; Oxidation-Reduction; Pancreatic Neoplasms; RNA, Messenger | 2019 |
Clinical Significance of Serum Glutamine Level in Patients with Colorectal Cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albumins; Biomarkers, Tumor; C-Reactive Protein; Carcinoembryonic Antigen; Colorectal Neoplasms; Cytokines; Disease Progression; Female; Glutamine; Humans; Inflammation; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Analysis; Young Adult | 2019 |
A novel function of anaphase promoting complex subunit 10 in tumor progression in non-small cell lung cancer.
Topics: A549 Cells; Apc10 Subunit, Anaphase-Promoting Complex-Cyclosome; Autophagy; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Cytoplasm; Disease Progression; G1 Phase; Glutaminase; Glutamine; Humans; Lung Neoplasms; Resting Phase, Cell Cycle; RNA, Small Interfering; Signal Transduction; Transfection | 2019 |
MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells.
Topics: Base Sequence; Cell Differentiation; Disease Progression; Down-Regulation; Glutaminase; Glutamine; Humans; Mesenchymal Stem Cells; MicroRNAs; Osteogenesis; Osteoporosis | 2019 |
Cognitive decline in prodromal Huntington Disease: implications for clinical trials.
Topics: Adult; Clinical Trials as Topic; Cognition Disorders; Disease Progression; DNA Mutational Analysis; Feasibility Studies; Female; Genetic Testing; Glutamine; Humans; Huntington Disease; Longitudinal Studies; Male; Middle Aged; Neurologic Examination; Neuropsychological Tests; Outcome Assessment, Health Care; Prodromal Symptoms; Trinucleotide Repeat Expansion | 2013 |
Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Topics: Adolescent; Adult; Aspartic Acid; Chronic Disease; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Prefrontal Cortex; Prodromal Symptoms; Psychotic Disorders; Risk; Schizophrenia; Young Adult | 2014 |
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.
Topics: Amino Acid Transport System y+; Animals; Cell Line, Tumor; Disease Progression; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glutamine; Glutathione; Humans; Mice; Prognosis; Reactive Oxygen Species; RNA, Small Interfering; Triple Negative Breast Neoplasms | 2013 |
Hippocampal neurochemical changes in senescent mice induced with chronic injection of D-galactose and NaNO₂: an in vitro high-resolution NMR spectroscopy study at 9.4T.
Topics: Amyloid; Animals; Apoptosis; Aspartic Acid; Behavior, Animal; Cell Proliferation; Congo Red; Disease Progression; Galactose; Glutamine; Hippocampus; Inositol; Magnetic Resonance Spectroscopy; Male; Maze Learning; Mice; Neurofibrillary Tangles; Neuroglia; Neurons; Sodium Nitrite; Time Factors | 2014 |
Elevated expression of glutaminase confers glucose utilization via glutaminolysis in prostate cancer.
Topics: Adenosine Triphosphate; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Disease Progression; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glucose; Glutamic Acid; Glutaminase; Glutamine; Glycolysis; Humans; Immunohistochemistry; Male; Neoplasm Invasiveness; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; RNA Interference | 2015 |
Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.
Topics: Blood-Brain Barrier; Brain Neoplasms; Disease Progression; Fluorine Radioisotopes; Glioma; Glutamine; Humans; Positron-Emission Tomography | 2015 |
Glutamate dehydrogenase is a novel prognostic marker and predicts metastases in colorectal cancer patients.
Topics: Aged; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Epithelial-Mesenchymal Transition; Female; Glutamate Dehydrogenase; Glutamine; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Prognosis; Proportional Hazards Models; Up-Regulation | 2015 |
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism.
Topics: Animals; Carcinoma, Renal Cell; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Genes, myc; Genes, ras; Glutaminase; Glutamine; Humans; Kidney Neoplasms; Lipid Metabolism; Mice; Mice, SCID; Mice, Transgenic; RNA, Messenger; RNA, Neoplasm; Spectrometry, Mass, Electrospray Ionization; Sulfides; Thiadiazoles; Up-Regulation | 2015 |
Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years.
Topics: Adult; Aged; Biomarkers; Disease Progression; Female; Follow-Up Studies; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Time Factors | 2016 |
Tumour-suppressive function of SIRT4 in human colorectal cancer.
Topics: Cell Movement; Cell Proliferation; Colorectal Neoplasms; Disease Progression; Genes, Tumor Suppressor; Glutamine; HCT116 Cells; HT29 Cells; Humans; Mitochondrial Proteins; Neoplasm Invasiveness; Prognosis; Sirtuins; Tumor Cells, Cultured | 2015 |
Prefrontal NAA and Glx Levels in Different Stages of Psychotic Disorders: a 3T 1H-MRS Study.
Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Aspartic Acid; Case-Control Studies; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Male; Middle Aged; Neurotransmitter Agents; Prefrontal Cortex; Proton Magnetic Resonance Spectroscopy; Psychotic Disorders; Regression Analysis; Risk; Severity of Illness Index; Time Factors | 2016 |
Metabolomic Analysis of Gastric Cancer Progression within the Correa's Cascade Using Ultraperformance Liquid Chromatography-Mass Spectrometry.
Topics: Adenocarcinoma; Biomarkers, Tumor; Chromatography, High Pressure Liquid; Disease Progression; Female; Gastritis; Glutamine; Helicobacter Infections; Helicobacter pylori; Humans; Kynurenine; Male; Mass Spectrometry; Metabolomics; Middle Aged; Plasma; Precancerous Conditions; Stomach Neoplasms; Tryptophan | 2016 |
Amplification of USP13 drives ovarian cancer metabolism.
Topics: Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Disease Progression; Endopeptidases; Female; Gene Amplification; Gene Knockdown Techniques; Genome, Human; Glutamine; HEK293 Cells; Humans; Lipids; Mitochondria; Neoplasm Metastasis; Ovarian Neoplasms; Protein Kinase Inhibitors; Protein Stability; Proto-Oncogene Proteins c-akt; Substrate Specificity; Ubiquitin-Specific Proteases; Ubiquitination | 2016 |
Altered glutamate metabolism contributes to antiepileptogenic effects in the progression from focal seizure to generalized seizure by low-frequency stimulation in the ventral hippocampus.
Topics: Animals; Cerebral Cortex; Dentate Gyrus; Disease Progression; Electric Stimulation; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Glutamic Acid; Glutamine; Hippocampus; Kindling, Neurologic; Male; Rats; Rats, Sprague-Dawley; Seizures | 2017 |
Increased Expression of Glutaminase in Osteoblasts Promotes Macrophage Recruitment in Periapical Lesions.
Topics: Animals; Blotting, Western; Cells, Cultured; Disease Progression; Glutaminase; Glutamine; Humans; Macrophages; Osteoblasts; Periapical Periodontitis; Rats; Rats, Sprague-Dawley | 2017 |
Nur7 is a nonsense mutation in the mouse aspartoacylase gene that causes spongy degeneration of the CNS.
Topics: Age Factors; Amidohydrolases; Animals; Animals, Newborn; Aspartic Acid; Axons; Behavior, Animal; Canavan Disease; Central Nervous System; Chromosome Mapping; Codon, Nonsense; Disease Models, Animal; Disease Progression; Glutamine; Lipid Metabolism; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelin Sheath; N-Acylsphingosine Galactosyltransferase; Oligodendroglia | 2008 |
Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations.
Topics: Adolescent; Adrenergic beta-Agonists; Albuterol; Asthma; Child; Child, Preschool; Disease Progression; Female; Genotype; Glutamic Acid; Glutamine; Glycine; Humans; Length of Stay; Male; Polymorphism, Single Nucleotide; Receptors, Adrenergic, beta-2; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2009 |
Conversion to dementia in mild cognitive impairment is associated with decline of N-actylaspartate and creatine as revealed by magnetic resonance spectroscopy.
Topics: Aged; Alzheimer Disease; Aspartic Acid; Brain; Choline; Cognition; Cognition Disorders; Creatine; Dementia; Disease Progression; Female; Follow-Up Studies; Glutamine; Humans; Inositol; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Memory; Middle Aged; Parietal Lobe; Prognosis; Severity of Illness Index | 2009 |
Arg753Gln polymorphism of the human Toll-like receptor 2 gene from infection to disease in pediatric tuberculosis.
Topics: Adolescent; Arginine; Child; Child, Preschool; Disease Progression; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Male; Mutation; Polymorphism, Genetic; Toll-Like Receptor 2; Tuberculosis, Pulmonary; Turkey | 2011 |
Retinal remodeling in the Tg P347L rabbit, a large-eye model of retinal degeneration.
Topics: Adult; Animals; Animals, Genetically Modified; Disease Models, Animal; Disease Progression; Electroretinography; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Glutathione; Glycine; Humans; Male; Opsins; Rabbits; Retina; Retinal Degeneration; Retinitis Pigmentosa; Taurine | 2011 |
Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.
Topics: Adenosine Triphosphate; Carcinoma; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Deoxyglucose; Disease Progression; Genes, p53; Glucose; Glutamine; Head and Neck Neoplasms; Humans; Lactic Acid; Mass Spectrometry; Metabolomics; Metformin; Neoplasms, Squamous Cell; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome; Tumor Suppressor Protein p53 | 2011 |
Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1).
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Cognition Disorders; Disease Progression; Family Health; Female; Glutamine; Humans; Longitudinal Studies; Lysine; Male; Mutation; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Time Factors | 2011 |
An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
Topics: Acetylation; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Glutamine; Histone Acetyltransferases; Histone Deacetylase Inhibitors; Histone Deacetylases; Histone-Lysine N-Methyltransferase; Histones; Humans; Methylation; Repressor Proteins | 2012 |
N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
Topics: Aged; Alzheimer Disease; Aspartic Acid; Choline; Cognitive Dysfunction; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Protons; Temporal Lobe | 2011 |
Glutamatergic changes in the cerebral white matter associated with schizophrenic exacerbation.
Topics: Adult; Brain; Brain Chemistry; Case-Control Studies; Disease Progression; Excitatory Amino Acids; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroimaging; Parietal Lobe; Schizophrenia | 2012 |
Astrocyte metabolism is disturbed in the early development of experimental hydrocephalus.
Topics: Acetates; Animals; Astrocytes; Biomarkers; Brain Stem; Carbon Isotopes; Disease Models, Animal; Disease Progression; gamma-Aminobutyric Acid; Glucose; Glutamic Acid; Glutamine; Hydrocephalus; Kaolin; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Neurotransmitter Agents; Predictive Value of Tests; Rats; Rats, Sprague-Dawley; Taurine; Telencephalon | 2003 |
Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene.
Topics: Adult; Arginine; Charcot-Marie-Tooth Disease; Disease Progression; DNA Mutational Analysis; Electrophysiology; Family; Female; Genes, Recessive; Glutamine; Humans; Male; Mutation; Nerve Tissue Proteins; Pedigree; Phenotype; Serine | 2003 |
The relationship of plasma glutamine to ammonium and of glycine to acid-base balance in propionic acidaemia.
Topics: Acid-Base Equilibrium; Amino Acid Metabolism, Inborn Errors; Bicarbonates; Biomarkers; Diet, Protein-Restricted; Disease Progression; Follow-Up Studies; Glutamine; Glycine; Humans; Propionates; Propionic Acidemia; Quaternary Ammonium Compounds | 2003 |
The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis.
Topics: Amino Acid Sequence; Apoptosis; Circular Dichroism; Disease Progression; Fas Ligand Protein; Gene Products, tat; Glutamine; HeLa Cells; HIV Infections; HIV-1; Humans; Jurkat Cells; Membrane Glycoproteins; Models, Molecular; Molecular Sequence Data; Protein Structure, Secondary; Protein Structure, Tertiary; Sequence Alignment; Structure-Activity Relationship; T-Lymphocytes; tat Gene Products, Human Immunodeficiency Virus; Transcriptional Activation; Tubulin; Uganda | 2004 |
Proton MR spectroscopy detected glutamate/glutamine is increased in children with traumatic brain injury.
Topics: Adolescent; Age Factors; Aspartic Acid; Brain; Brain Injuries; Child; Child, Preschool; Choline; Coma; Disease Progression; Female; Glutamic Acid; Glutamine; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Nerve Degeneration; Occipital Lobe; Parietal Lobe; Predictive Value of Tests; Recovery of Function; Up-Regulation | 2004 |
Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients.
Topics: Adolescent; Adrenoleukodystrophy; Aspartic Acid; Brain Chemistry; Child; Child, Preschool; Creatine; Disease Progression; Follow-Up Studies; Glutamine; Hematopoietic Stem Cell Transplantation; Humans; Inositol; Lactates; Lipids; Magnetic Resonance Spectroscopy; Male; Neuropsychological Tests; Prognosis | 2005 |
The 5alpha-reductase type II A49T and V89L high-activity allelic variants are more common in men with prostate cancer compared with the general population.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Alanine; Alleles; Arginine; Biomarkers, Tumor; Case-Control Studies; Dihydrotestosterone; Disease Progression; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Glutamine; Humans; Leucine; Luteinizing Hormone; Male; Middle Aged; Point Mutation; Polymorphism, Genetic; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, Androgen; Risk Factors; Sex Hormone-Binding Globulin; Sweden; Terminal Repeat Sequences; Testosterone; Threonine; Valine | 2005 |
Brain metabolic markers reflect susceptibility status in cytokine gene knockout mice with murine cerebral malaria.
Topics: Animals; Brain; Cytokines; Disease Models, Animal; Disease Progression; Disease Susceptibility; Glucose; Glutamine; Magnetic Resonance Spectroscopy; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Mice, Knockout | 2006 |
Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis.
Topics: Age Factors; Amyotrophic Lateral Sclerosis; Analysis of Variance; Animals; Aspartic Acid; Disease Models, Animal; Disease Progression; gamma-Aminobutyric Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Transgenic; Mutation; Nerve Degeneration; Superoxide Dismutase; Time Factors | 2007 |
Magnetic resonance spectroscopy in adult-onset citrullinemia: elevated glutamine levels in comatose patients.
Topics: Adult; Ammonia; Biomarkers; Brain; Brain Mapping; Cerebral Cortex; Choline; Citrulline; Citrullinemia; Coma; Diffusion Magnetic Resonance Imaging; Disease Progression; Early Diagnosis; Fatal Outcome; Glutamic Acid; Glutamine; Gyrus Cinguli; Humans; Hyperammonemia; Inositol; Magnetic Resonance Spectroscopy; Male; Predictive Value of Tests | 2007 |
Sanfilippo syndrome type D: natural history and identification of 3 novel mutations in the GNS Gene.
Topics: Adolescent; Adult; Aspartic Acid; Disease Progression; DNA Mutational Analysis; Family Health; Female; Glutamine; Glycine; Humans; Male; Mucopolysaccharidosis III; Mutation; Sulfatases | 2007 |
Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease.
Topics: Animals; Asparagine; Cell Differentiation; Cell Movement; Disease Models, Animal; Disease Progression; Glutamine; Huntington Disease; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Sertraline | 2008 |
Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease.
Topics: Adult; Ataxin-3; Ataxins; Cell Nucleus; Disease Progression; DNA-Binding Proteins; Fatal Outcome; Female; Glutamine; Humans; Hyalin; Immunohistochemistry; Inclusion Bodies; Macromolecular Substances; Male; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Nuclear Proteins; Proteins; Repressor Proteins; TATA-Box Binding Protein; Transcription Factors; Trinucleotide Repeats; Ubiquitins | 2001 |